Q4 2024 Earnings Estimate for HCA Healthcare, Inc. (NYSE:HCA) Issued By Leerink Partnrs

HCA Healthcare, Inc. (NYSE:HCA) – Analysts at Leerink Partnrs upped their Q4 2024 earnings per share (EPS) estimates for HCA Healthcare in a research report issued on Tuesday, July 23rd. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn $6.46 per share for the quarter, up from their previous estimate of $5.70. The consensus estimate for HCA Healthcare’s current full-year earnings is $22.38 per share. Leerink Partnrs also issued estimates for HCA Healthcare’s Q1 2025 earnings at $6.00 EPS and Q4 2025 earnings at $7.34 EPS.

HCA has been the subject of several other research reports. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Deutsche Bank Aktiengesellschaft increased their price objective on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a report on Friday, June 28th. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. JPMorgan Chase & Co. lifted their price objective on HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a research note on Thursday, May 30th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $335.00 price objective on shares of HCA Healthcare in a research report on Wednesday. Four investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $339.72.

HCA Healthcare Stock Performance

Shares of HCA opened at $352.79 on Friday. The firm has a fifty day moving average of $329.48 and a 200-day moving average of $322.74. The company has a market cap of $92.40 billion, a price-to-earnings ratio of 17.59, a price-to-earnings-growth ratio of 1.38 and a beta of 1.68. HCA Healthcare has a 1 year low of $215.96 and a 1 year high of $356.30. The company has a debt-to-equity ratio of 27.11, a quick ratio of 1.02 and a current ratio of 1.06.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the company posted $4.29 EPS.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

Insider Activity at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 973 shares of the stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the sale, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,863 shares of HCA Healthcare stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the transaction, the senior vice president now owns 19,612 shares of the company’s stock, valued at approximately $6,397,042.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Kathryn A. Torres sold 973 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the transaction, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock valued at $3,921,929 in the last three months. Corporate insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

A number of large investors have recently bought and sold shares of the stock. Norges Bank bought a new position in HCA Healthcare in the 4th quarter worth $694,985,000. Royal Bank of Canada grew its stake in shares of HCA Healthcare by 35.7% in the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock worth $1,219,121,000 after acquiring an additional 1,183,890 shares during the last quarter. Capital World Investors boosted its stake in HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after purchasing an additional 1,019,750 shares during the last quarter. Sanders Capital LLC lifted its holdings in shares of HCA Healthcare by 4.2% during the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after buying an additional 456,738 shares during the period. Finally, TD Asset Management Inc boosted its stake in shares of HCA Healthcare by 230.5% during the 4th quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock worth $149,747,000 after acquiring an additional 385,854 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.